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Burkholderia contaminans strain MS14 produces the antifungal compound occidiofungin, which is responsible for significant
antifungal activities against a broad range of plant and animal fungal pathogens. Occidiofungin is a cyclic glycolipopeptide made
up of eight amino acids and one xylose. A 56-kb ocf gene cluster was determined to be essential for occidiofungin production. In
this study, the ocfC gene, which is located downstream of ocfD and upstream of the ocfB gene in the ocf gene cluster, was exam-
ined. Antifungal activity of the ocfC gene mutant MS14KC1 was reduced against the indicator fungus Geotrichum candidum
compared with that of the wild-type strain. Furthermore, the analysis of the protein sequence suggests that the ocfC gene en-
codes a glycosyltransferase. Biochemical analyses using nuclear magnetic resonance (NMR) andmass spectroscopy revealed that
the ocfCmutant produced the occidiofungin without the xylose. The purified ocfCmutant MS14KC1 product had a level of bio-
activity similar to that of the wild-type product. The revertant MS14KC1-R of the ocfCmutant produced the same antifungal
activity level on plate assays and the same antifungal compound based on high-performance liquid chromatography (HPLC) and
mass spectroscopy analysis as wild-type strainMS14. Collectively, the study demonstrates that the ocfC gene encodes a glycosyl-
transferase responsible to add a xylose to the occidiofungin molecule and that the presence of the xylose is not important for
antifungal activity against Candida species. The finding provides a novel variant for future studies aimed at evaluating its use for
inhibiting clinical and agricultural fungi, and the finding could also simplify the chemical synthesis of occidiofungin variants.
Members of the bacterial genus Burkholderia exist naturally inenvironments such as water, soil, and the rhizosphere of
crop plants (1). Some Burkholderia strains show striking efficacy
in controlling fungal diseases of crops as biological control agents
for plant disease management (2). However, the use of Burkhold-
eria strains is prohibited because of difficulty taxonomically dif-
ferentiating these beneficial strains from the strains that are op-
portunistic pathogens associated with the human disease cystic
fibrosis (1). Understanding themolecularmechanisms of antifun-
gal activities of the Burkholderia strains will provide important
clues for the development of biologically based fungicides while
eliminating potential health risks.
Burkholderia contaminans strain MS14 showed a broad range
of antifungal activity to plant and human fungal pathogens (3). A
glycopeptide named occidiofungin produced by strain MS14 is
responsible for its antifungal activity (4, 5). It is a cyclic glycopep-
tide made up of eight amino acids and one xylose (6). Four vari-
ants, named occidiofungin A, B, C, and D, have been identified
from the MS14 strain culture (6). Occidiofungin inhibits the
growth of a broad range of fungal pathogens, and it was shown to
inhibit the production of the cell wall ofGeotrichum candidum (6).
The compounds have shown great potential for pharmaceutical
and agricultural applications (7, 8).
Genetic analysis revealed that a 56-kb ocf gene cluster is re-
quired for production of antifungal activity by Burkholderia con-
taminans strainMS14. Sixteen genes have been predicted in the ocf
gene cluster, including the genes encoding nonribosomal peptide
synthetases (ocfD, ocfE, ocfF, ocfH, and ocfJ), the bacterial LuxR
regulatory proteins (ambR1 and ambR2), and an ATP-binding
cassette (ocfA) (6). Mutagenesis and sequence analysis revealed
that these genes are associated with occidiofungin production by
strain MS14. Functions of a few genes in the ocf gene cluster, such
as ocfC, remain to be investigated. Preliminary analysis showed
that the deduced protein of the ocfC gene shares a significant sim-
ilarity to galactosyltransferases. We hypothesized that the ocfC
gene codes for an enzyme to catalyze the addition of xylose to the
backbone peptide of occidiofungin. In this study, the ocfC gene
was disrupted with an insertional mutation, and effects of the
mutation on occidiofungin production were evaluated. Possible
functions of the ocfC gene are discussed.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. Bacterial strains and plasmids
used in this study are listed in Table 1. Escherichia coli JM109 (Promega,
Madison, WI) was used for cloning and was cultured at 37°C on Luria-
Bertani (LB) agar. The medium super optimal broth (SOC) was used to
grow transformed bacterial cells (13). Nutrient broth-yeast extract (NBY)
agar medium (14) was used to culture Burkholderia contaminans strain
MS14 at 28°C. Potato dextrose agar (PDA) (Difco, Detroit, MI) was used
for antifungal activity assays. Antibiotics (Sigma Chemical Co., St. Louis,
MO)were added tomedia at the following concentrations: ampicillin, 100
g/ml; kanamycin, 100 g/ml for Escherichia coli and 300 g/ml for the
MS14 mutants; and trimethoprim, 50 g/ml.
DNA isolation, manipulation, and sequence analysis. The cetyl tri-
methyl ammonium bromide protocol (15) or Wizard genomic DNA pu-
rification kit (Promega Corporation, Madison, WI) was used for extrac-
tion of bacterial genomic DNA. Primers were synthesized by Integrated
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DNA Technologies Inc. (Coralville, IA) and Eurofins MWG Operon
(Huntsville, AL). Plasmid extraction was done using the QIAprep spin
miniprep kit (Qiagen Inc., Valencia, CA). Wizard SV gel and PCR
clean-up system kit (Promega) was used to recover DNA fragments for
cloning. Sequencing was sent to Eurofins MWG Operon. The evolution-
ary history of the putative OcfC was inferred using the minimum evolu-
tion method (16). The evolutionary distances were computed using the
Poisson correctionmethod (17). Phylogenetic analyses were conducted in
MEGA4 (18).
Mutagenesis of the ocfC gene. Primers 6471R1649 (5=-GCCTACCT
GCGCGTCTATCA) and 6471F137 (5=-CCATGGCGGCGATTTGCTT
TGA) were designed in order to amplify the ocfC gene by PCR. The final
concentrations of PCR reagents in the 50-l reaction mixture were
MgCl2, 2 mM; dNTPs, 0.4 mM; primers, 0.6 mM each; Taq DNA poly-
merase, 0.75 units. The PCR cycling conditions were 4 min at 95°C, and
then 50 s at 95°C, 50 s at 56°C, and 2min at 72°C for 30 cycles, followed by
8 min at 72°C. The PCR amplicon containing the ocfC gene with the
flanking regions was cloned into the vector pGEM-T Easy (Promega) to
generate the plasmid pKC1. Plasmid pBSL15 (12) was partially digested
with EcoRI and then self-ligated to remove the restriction endonuclease
EcoRI digestion site as described previously (19). A 1.3-kb PstI fragment
of the plasmid pBSL15 lacking the EcoRI site and carrying the termina-
torless kanamycin cassette (the nptII gene fragment) was cloned into the
ocfC gene of the plasmid pKC1 using a PstI partial digestion strategy. The
resulting plasmid pGEM-T Easy-ocfC::nptII was named pKC2. The ocfC::
nptIIDNA fragment was introduced to the EcoRI site of the suicide vector
pBR325 (10) for Burkholderia spp. (20) to generate plasmid pKC3. Plas-
mid pKC3was electroporated into competent cells of the wild-typeMS14,
which was prepared using the 10% glycerol-washing protocol (21), for
marker exchange mutagenesis (capacitance, 25 F; resistance, 200 ;
voltage, 1.8 KV; and cuvette path length, 1mm).NBYmedium containing
kanamycin (300 g/ml) was used for selection of the mutants. PCR am-
plification and sequencing were used for confirmation of double-cross-
over mutagenesis. Plate bioassays were used to evaluate the production
and biological activity of occidiofungin as described previously (9).
The intact ocfC gene was obtained by PCR for the complementary
assays. Primers ocfC-compF (5=-CGGAATTCCATGTCAATTCGTTT
CTG) and ocfC-compR (5=-TTAAGCTTCGCTTCGAGGTCAACGGT)
were designed for PCR amplification of the functional ocfC gene. The
purpose of these two primers is to add EcoRI and HindIII sites to the
respective ends of the PCR product. The 0.8-kb PCR product was inserted
into the Burkholderia gene expression vector pMLS7 digested with EcoRI
and HindIII, to generate pKC4. Plasmid pKC4 was electroporated into
cells of themutantMS14KC1.NBYplates with trimethoprimwere used to
screen for colonies with pMLS7 (11), which were confirmed by sequenc-
ing. Complementation experiments were done by the plate assay to exam-
ine the antifungal activity against G. candidum.
Reversion of the ocfC mutant into its wild genotype. To revert the
ocfC mutant into its wild genotype, plasmid pDP12 was generated for
marker exchange gene replacement. The 1.5-kb EcoRI fragment of pKC1
was cloned into the EcoRI site of the suicide vector pBR325. To obtain the
revertants of the ocfC mutant MS14KC1, plasmid pDP12 was electropo-
rated into MS14KC1 cells for marker exchange. Transformed cells were
cultured in the broth SOC with shaking for 4 h. The bacterial diluted cells
were plated on NBY agar supplemented with 100 g/ml of kanamycin.
The resulting single colonies were copied onto NBY plates supplemented
with 300 g/ml of kanamycin. The colonies that were able to grow on the
NBY plates supplemented with 100 g/ml kanamycin but not 300 g/ml
were selected as candidates of the revertants. The revertants were con-
firmed by PCR analysis compared with the mutant MS14KC1 and the
wild-type strain MS14. Verified revertant MS14KC1-R was used for fur-
ther analyses of occidiofungin production.
Isolation of the antifungal compound of the mutant MS14KC1 and
MS14KC1-R. Isolation and purification of the occidiofungin variant pro-
duced by the ocfC mutant and its revertant were conducted as described
previously (9). In brief, the bacterial strains were incubated at 28°C for 7
days without shaking. The cell-free culture extract was precipitated using
ammonium sulfate (AS) (50%, wt/vol) on ice for 2 h. The pellet was
resuspended in 1 ml of 35% acetonitrile (ACN)-water (vol/vol) and
placed in a 1.5-ml microcentrifuge tube. Reversed-phase HPLC was done
using a 4.6- by 250-mmC18 column (Grace-Vydac; catalog no. 201TP54)
on a Bio-Rad BioLogic F10 Duo Flow with Quad Tec UV-Vis detector
system.
In vitro susceptibility testing.Microdilution broth susceptibility test-
ing was performed in triplicate according to the CLSI M27-A3 method
(22) in RPMI 1640 (buffered to a pH of 7.0 with MOPS [morpholinepro-
panesulfonic acid]) growth medium. Stock solutions (100) of occidio-
fungin were prepared in dimethyl sulfoxide (DMSO). MIC endpoints for
occidiofungin were determined by visual inspection and were based on
the wells that had no visible growth (an optically clear well) after 24 h of
incubation. DMSO containing no antifungal agent was used as a negative
control.
NMR spectroscopy. The same procedure for NMR analysis was used
as described previously (6). Occidiofungin was dissolved in deuterated
dimethyl sulfoxide (DMSO-d6), and the NMR data were collected on a
Bruker Avance DRX spectrometer with a CryoProbe, operating at a pro-
ton frequency of 600MHz. The 1H resonances were assigned according to
standard methods (23) using correlation spectroscopy (COSY), total cor-
relation spectroscopy (TOCSY), nuclear Overhauser effect spectroscopy
(NOESY), and carbon 13 heteronuclear single-quantum correlation spec-
troscopy (13C-HSQC) experiments. NMR experiments were collected at
25°C. The TOCSY experiment was acquired with a 60-ms mixing time
using the BrukerDIPSI-2 spinlock sequence. TheNOESY experiment was
acquiredwith 400-msmixing times. Phase-sensitive indirect detection for
NOESY, TOCSY, andCOSY experiments was achieved using the standard
Bruker pulse sequences. Peaks were assigned using NMRView (24).
Mass spectrometry. Molecular weight of the occidiofungin variant
produced byMS14KC1 was measured as described previously (5, 9). Ma-
trix-assisted laser desorption/ionization–time of flightmass spectrometry
(MALDI-TOFMS; Shimadzu/Kratos) was used to determine the mass of
peaks. The antifungal HPLC fraction was evaporated to dryness and was
TABLE 1 Bacterial strains and plasmids
Strain or plasmid Relevant characteristic(s)a
Source or
reference
Strains
E. coli JM109 recA1 endA1 gyrA96 thi hsdR17 supE44 relA1
(lac-proAB)/F=[traD26 rpoAB laclq
lacZM15]
Promega
B. contaminans
MS14 Wild-type strain 9
MS14KC1 ocfC::nptII derivative of MS14; Kmr This study
MS14MT18 ocfE::Tn5 derivative of MS14; Kmr 6
MS14KC1-R Revertant strain of the ocfC::nptIImutant This study
Plasmids
pBR325 Cloning vector; Cmr Tcr Apr 10
pMLS7 Expression vector of Burkholderia; Tpr 11
pGEM-T Easy Cloning vector; Apr Promega
pBSL15 Kanamycin resistance gene cassette; Kmr 12
pKC1 pGEM-T Easy carrying 1.5-kb PCR product
containing the intact ocfC gene; Apr
This study
pKC2 pGEM-T Easy containing 2.8-kb ocfC and
nptII; Kmr
This study
pKC3 pBR325 carrying 2.8-kb EcoRI fragment
containing the intact ocfC gene; Kmr Tcr Apr
This study
pKC4 pMLS7 carrying 1.5-kb PCR product
containing the intact ocfC gene; Cmr Tpr
This study
pDP12 pBR325 carrying 1.5-kb EcoRI fragment of
pKC1 containing the intact ocfC gene; Kmr
Tcr Apr
This study
a Kmr, kanamycin resistance; Apr, ampicillin resistance; Tpr, trimethoprim resistance;
Cmr, chloramphenicol resistance.
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dissolved in 100 l of 35% acetonitrile containing 0.1% trifluoroacetic
acid. From these resuspended fractions, 0.5 l was mixed with 0.5 l of
-cyano-4-hydroxycinnamic acid matrix (6 mg/ml in 50% acetonitrile
containing 0.1% trifluoroacetic acid) and dried on the target plate.
RESULTS
Sequence analysis of the ocfC gene. The ocfC gene is located
downstream of the ocfD gene and upstream of the ocfB gene in the
ocf gene cluster (GenBank accession number EU938698) (6). No
significant promoter region or terminator was identified from the
5= and 3= termini of the ocfC gene, suggesting that the ocfC gene
may be organized as a transcriptional operon with the down-
stream and upstream genes. The 657-bp ocfC gene was predicted
to code for a 218-amino-acid putative protein which was pre-
dicted to be the glycosyltransferase that catalyzes the transfer of a
xylose to the C-7 site of occidiofungin (6). Sequence analysis
showed that this putative protein encoded by the ocfC gene shared
94.0% identity with the putative glycosyltransferase (Bamb_6471)
of Burkholderia ambifaria AMMD (GenBank accession number
NC_008392). A BLAST search showed there is one conserved do-
main from amino acids 13 to 89 on the OcfC protein, which is the
signature of the glycosyltransferase family 25 (25). According to
the phylogenetic analysis, the OcfC putative protein of Burkhold-
eria contaminansMS14 is clustered with Bamb_6471 of Burkhold-
eria ambifaria AMMD with a bootstrap value of 100, and both
were predicted to bemembers of the glycosyltransferase family 25.
The Xcc-b100_0220 protein for Xanthomonas campestris pv.
campestrisB100 (26) and the PXO_04234 protein ofXanthomonas
oryzae pv. oryzae PXO99A (27) shared 55% of similarity to OcfC.
Site-directed mutagenesis of the ocfC gene. A 1.5-kb PCR
product was amplified using the primers 6471R1649 and
6471F137 and confirmed by sequencing to be the ocfC gene with
its flanking regions. Sequencing further confirmed the identity of
the plasmid pKC1, which is the vector pGEM-T Easy carrying the
ocfC gene. An insertionalmutationwas obtained by insertion of an
nptII cassette, resulting in plasmid pKC2. The plasmid pKC3 was
obtained by cloning the nptII-disrupted ocfC gene into pBR325.
Introduction of pKC3 into cells of strain MS14 resulted in gener-
ation of the ocfCmutantMS14KC1, which was confirmed by PCR
and sequencing.
Effect of mutation in ocfC on antifungal activity. Mutant
MS14KC1 with an insertion in the nptII gene cassette was evalu-
ated for occidiofungin production by inhibitory activities
against the indicator fungus G. candidum (Fig. 1). The ability of
MS14KC1 to inhibit the growth of theG. candidum indicator fun-
gus remained with a reduced inhibitory zone (0.82 0.02 cm). In
contrast, the antifungal activity for wild-type strain MS14 was
1.42 0.06 cm in radius. The disruption of the ocfC gene caused a
42% decrease in the antifungal activity againstG. candidum (Fig. 1).
Based on the Fisher’s least significant difference (LSD) test, this
was a significant difference ( 0.05). As expected, the revertant
FIG 1 Plate bioassays for antifungal activities of Burkholderia contaminans strains against indicator fungus Geotrichum candidum. (A) The wild-type strain
MS14; (B)MS14KC1, ocfC::nptII; (C)MS14KC1-R, a revertant of the ocfCmutant; (D)MS14MT18, ocfE::Tn5. Potato dextrose agar plates were inoculated with
each strain (5 l containing	106 cells), and the inoculated plates were incubated at 28°C for 4 days. The plates were oversprayed with spore suspensions of the
indicator fungus G. candidum Km and further incubated at 28°C overnight.
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strain MS14KC1-R produced the wild-type level of antifungal ac-
tivity against G. candidum. As a negative control, the mutant
MS14MT18, in which the biosynthetase gene ocfE is knocked out
by a transposon (6, 9), did not produce measurable antifungal
activity. These results revealed the importance of the ocfC gene for
the production of the antifungal activity of strain MS14. Interest-
ingly, no significant restoration of antifungal activitywas observed
when the mutant MS14KC1 harbored an intact ocf gene that was
under the control of the plac promoter in the broad-host-range
vector pMSL7. A significant reduction of occidiofungin produc-
tion by the ocfC mutant was observed compared to that by the
wild-type strain. The average yields per liter of the wild-type and
ocfC mutant products were approximately 350 g/liter (average
taken from 9 liters) and 47 g/liter (average taken from 10.5 li-
ters), respectively. The 7-fold reduction in yield indicates that the
attachment of the xylose might be important for biosynthesis or
transport.
Chemical structureof theoccidiofunginvariantproducedby
the ocfC mutant. NMR analysis reveals a loss of the xylose from
the wild-type product in the ocfC mutant (Fig. 2A and B). Com-
parison of the TOCSY spectrum of the product from the ocfC
mutant to the wild-type product reveals the loss of the proton
chemical shifts for the xylose sugar.MALDI-TOFMS analysis also
reveals the loss of the xylose sugar. The product of the ocfCmutant
has a base mass of 1,068.73 Da (Fig. 2C), which correlates to the
loss of a pentose sugar (149 Da) plus the addition of a hydroxyl
group remaining on the antifungal compound. The NMR spec-
trum of occidiofungin has multiple spin systems for each amino
acid due to different conformers on the NMR time scale. Interest-
ingly, the spectrum is complex for a peptide that is only eight
amino acids (Fig. 3A). The ocfC mutant product has a far less
complex spectrum than the wild type (Fig. 3B and Table 2). This is
due to the loss of the bulky xylose sugar which presumably allows
the compound to interchange between conformations more
freely. This is reflected in the loss of conformational families in the
NMR spectra for Asn1, BHY4 Gly6, and Asn7 (Fig. 3C). The con-
formational families that aremissing in the ocfCmutant have been
highlighted green in the overlays of the wild-type and mutant
spectra. Cyclization of the peptide is carried out by two cyclase
thioesterases that form two distinct conformational families of
occidiofungin. These conformational families are visible in the
ocfC mutant spectrum and are easily observed by the presence of
two different amide proton frequencies for Asn1 and NAA2.
Therefore, the loss of the xylose sugar does not affect the forma-
tion of these two conformational groups of the antifungal com-
pound.
Effects of the ocfC mutation on production and antifungal
activity of occidiofungin. Occidiofungin products of the wild-
type and the ocfC mutant MS14KC1 were purified by RP-HPLC.
The ocfCmutant product eluted with a lower percentage of water
(46%) than the wild-type product (49%) (Fig. 4). Additionally,
the ocfC mutant product did not elute as a doublet peak as ob-
served in thewild-type fraction. Presumably, the observed doublet
peak in the wild-type fraction is attributed to the presence of the
FIG 2 Absence of xylose in the ocfCmutant product. (A) Region of the TOCSY spectrum showing the proton chemical shifts of xylose in the wild-type sample;
(B) region of the TOCSY spectrum showing the absence of the xylose in the ocfC mutant product sample; (C) MALDI-TOF MS spectrum of the ocfC mutant
product showing a base mass of 1,068 Da, which is a loss of 132 Da compared to the wild-type product mass.
FIG 3 TOCSY fingerprint region (amide correlations). (A) Amide correlations in the wild-type sample; (B) amide correlations in the ocfCmutant sample; (C)
overlay of the amide correlations found in the wild-type andmutant samples. NH correlations that are not present in the ocfCmutant sample are colored green.
Chen et al.
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xylose, and its presence contributes to conformational variants
that have slightly different retention times. NMR analyses also
revealed the loss of conformers (Fig. 3). As expected, product iso-
lated from ocfC revertant strain (MS14KC1-R) has the same RP-
HPLC retention time and mass as the wild-type product (Fig. 5).
MIC assay was conducted according to the CLSI M27-A3
method to determine whether the loss in activity in the G. candi-
dum overlay assay was attributed to the loss of the xylose or a
reduction in production. Comparing the purified wild-type and
the ocfC mutant product on several strains of the genus Candida,
G. candidum, and Saccharomyces cerevisiaeprovided a quantitative
assessment of the bioactivity of the mutant product. The results
are listed in Table 3. The ocfCmutant product essentially had the
same antifungal activity as the wild-type product in the in vitro
assay. Presumably, the addition of xylose may help promote sol-
ubility under normal environmental conditions. The RP-HPLC
chromatograms do reveal that the ocfC mutant product had a
longer retention time with an increased percentage of the organic
solvent acetonitrile (Fig. 4).
DISCUSSION
The ocfC gene encodes a member of the GT25 family of glycosyl-
transferases. Glycosyltransferases are identified from various or-
ganisms and classified based on amino acid sequence similarity
(28). The GT25 family includes the known members of beta-1,4-
galactosyltransferase and lipopolysaccharide biosynthesis protein
(29). For Haemophilus influenzae, glycosyltransferase LpsA is re-
sponsible for the addition of a hexose which can be either glucose
or galactose (30). Previous GC-MS analysis has showed that a
xylose sugar is attached to the antifungal compound occidiofun-
gin (6). In this study, we hypothesized that the ocfC gene codes for
glycosyltransferase, which was predicted to add xylose to the oli-
gopeptide backbone to form occidiofungin. This is proved by the
sequence analysis showing that this putative protein encoded by
the ocfC gene shared 94.0% identity to glycosyltransferase of B.
ambifaria AMMD in the phylogenetic tree generated. The known
activities of the GT25 family include beta-1,4-galactosyltrans-
ferase, beta-1,3-glucosyltransferase, beta-1,2-glucosyltransferase,
and beta-1,2-galactosyltransferase (31). This study is the first evi-
dence that xylosyltransferase is found in the GT25 family. This
novel glycosyltransferase has expanded the function categories of
this family. Based on the evidence of this study, glycosyltransferase
encoded by the ocfC gene should be named xylosyltransferase.
The ocfC gene is important for the production of occidiofun-
gin. The ocfCmutant strainMS14KC1has approximately 42% less
inhibitory activity to G. candidum than the wild-type strain, and
the occidiofungin yield of the mutant was decreased significantly
compared with that of the wild-type strain. The revertant strain
MS14KC1-R, inwhich the ocfC::nptIIDNA fragmentwas replaced
with the wild-type ocfC gene, restored the wild-type level of anti-
fungal activity. More importantly, the function of the ocfC gene to
add xylose to the occidiofungin molecule was further verified by
RP-HPLC andMALDI-TOFMS analyses. The results further con-
firmed the role of the ocfC gene in occidiofungin biosynthesis. The
broad-host-range vector pMLS7 was successfully used to comple-
FIG 4 Overlaid RP-HPLC chromatogram obtained from the extracts of both
the wild-type strain MS14 (black) and the ocfCmutant (gray).
TABLE 2 Chemical shift values for the ocfC mutant product
Amino acid
Chemical shift value(s)a
HN H H
 Other proton(s)
Asn1 8.13 4.53 [52.91] 2.58, 2.36 [40.09] -NH2, 7.23, 6.84
BHN1 7.95 4.62 [58.79] 4.03 [74.94] -NH2, 7.20, 6.77; 
-OH, 5.71
NAA2 7.49 C-2:CH2, 2.38 [39.98]; C-3:CH, 4.14 [47.49]; C-4:CH2, 1.77 [41.32]
7.35 C-2:CH2, 2.32 [43.78]; C-3:CH, 4.19 [47.49]; C-4:CH2, 1.39 [41.32]
Ser3 8.13 4.21 [58.90] 
-OH, 5.08
8.18 4.18 [58.81] 
-OH, 5.08
BHY4 8.02 4.18 [63.07] 5.08 [73.89] 
-OH, 5.70
DABA5 7.71 4.39 [53.86] 2.11, 1.91 [32.78] -H, 2.92 [32.78]; NH2, 7.74
Gly6 7.93 3.81, 3.64 [45.11]
7.85 3.87, 3.65 [45.11]
Asn7 8.36 4.58 [58.71] 2.63, 2.41 [40.09] -NH2, 7.38, 6.92
8.30 4.56 [52.91] 2.63, 2.40 [40.09] -NH2, 7.38, 6.92
Ser8 7.81 4.20 [58.70] 3.62 [63.07] 
-OH, 5.69
a Proton chemical shift values are from TOCSY and NOESY experiments. Chemical shifts in brackets are 13C values from the HSQC experiment.
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ment the phenotype of themutantMS14GG44 to that of the wild-
type strain B. contaminans MS14 (19). Surprisingly, like other
studies (32), a functional ocfC gene did not fully restore occidio-
fungin production of the mutant MS14KC1. The downstream
genes of ocfC include the ABC transporter gene (ocfB), the hypo-
thetical gene (ocfA), and the regulator gene (ambR2), which have
the same transcriptional orientation (6). However, the mutation
was made by the insertion of a terminatorless nptII gene (12),
which should not have any polar impacts on the expression of the
downstream genes (33). The phenotype of the mutant MS14KC1
resulted from the disruption of the targeted gene ocfC. It is spec-
ulated that the accurate balance of gene expression based on the
correct genomic position and gene dosage of ocfC may be critical
for its function.
The derivative of occidiofungin produced by the ocfC mutant
MS14KC1 lacks xylose, which is confirmed by both NMR and
MALDI-TOF MS analyses. As noted in the TOCSY fingerprint
analyses, the xylose-free occidiofungin has a far less complex spec-
trum than the wild-type occidiofungin, which may be due to the
loss of the sugar which allows the compound to interchange be-
tween conformations more freely. The two distinct conforma-
tional families of occidiofungin (6) carried by two cyclase thioes-
terases have been observed in the xylose-free occidiofungin, which
suggests that the xylose sugar is not an important component for
the cyclization step in occidiofungin production.
The mechanism by which the sugar xylose affects the produc-
tion of occidiofungin remains to be investigated. In this study, a
mutation of the ocfC gene results in significant reduction of occid-
iofungin production based on the standard plate bioassays, and
the yield of the xylose-free occidiofunginwas decreased in the ocfC
mutant. However, the purified xylose-free occidiofungin, which is
produced by the mutant MS14KC1, showed antifungal activity
similar to that of the wild-type occidiofungin product. We hy-
pothesize that xylose in occidiofungin may be associated with ef-
ficient secretion or for the biosynthesis. However, sonication of
the bacterial pellet did not improve the yield of the occidiofungin,
which indicates the produced occidiofungin may not be signifi-
cantly accumulated in bacterial cells. It is possible that the lower
yield is attributed to the insertion of a terminatorless nptII gene,
lowering the production of the downstream gene products. This is
not likely given the number of reports that have shown that the
cassette is nonpolar (33, 34). Collectively, there is no significant
impact of xylose on the peptide backbone and no significant effect
of xylose on antifungal activity of purified occidiofungins. More
investigations are needed to understand the effect of xylose on
occidiofungin production.
In conclusion, this study demonstrated that the ocfC gene en-
coding glycosyltransferase is responsible for the addition of xylose
to the occidiofungin molecule. This discovery has provided im-
portant genetic and enzymatic clues for engineering new chemical
variants of occidiofungin thatmay have applications in treating or
preventing fungal infections in plants and animals.
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